CVE-2008-1304

Description

Multiple cross-site scripting (XSS) vulnerabilities in WordPress 2.3.2 allow remote attackers to inject arbitrary web script or HTML via the (1) inviteemail parameter in an invite action to wp-admin/users.php and the (2) to parameter in a sent action to wp-admin/invites.php.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 2.15% Top 20%
Third-Party Advisory securityreason.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/archive/1/489241/100/0/threaded mailing list
http://www.hackerscenter.com/index.php?/Latest-posts/114-WordPress-Multiple-Cross-Site-Scripting-Vulnerabilities.html?id=114
https://exchange.xforce.ibmcloud.com/vulnerabilities/41055 vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/41056 vdb entry
http://www.securityfocus.com/bid/28139 vdb entry
http://securityreason.com/securityalert/3732 third party advisory
http://securitytracker.com/id?1019564 vdb entry

Frequently Asked Questions

What is the severity of CVE-2008-1304?
CVE-2008-1304 has been scored as a medium severity vulnerability.
How to fix CVE-2008-1304?
To fix CVE-2008-1304, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-1304 being actively exploited in the wild?
It is possible that CVE-2008-1304 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.